P Duchêne-Marullaz
About
In The Last Decade
P Duchêne-Marullaz
98 papers receiving 624 citations
Peers
Comparison fields: 5 of 86
- Cardiology and Cardiovascular Medicine 407
- Molecular Biology 285
- Cellular and Molecular Neuroscience 112
- Physiology 75
- Surgery 58
Countries citing papers authored by P Duchêne-Marullaz
This map shows the geographic impact of P Duchêne-Marullaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Duchêne-Marullaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Duchêne-Marullaz more than expected).
Fields of papers citing papers by P Duchêne-Marullaz
This network shows the impact of papers produced by P Duchêne-Marullaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Duchêne-Marullaz. The network helps show where P Duchêne-Marullaz may publish in the future.
Co-authorship network of co-authors of P Duchêne-Marullaz
This figure shows the co-authorship network connecting the top 25 collaborators of P Duchêne-Marullaz. A scholar is included among the top collaborators of P Duchêne-Marullaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Duchêne-Marullaz. P Duchêne-Marullaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 8 | |
| 4 | 9 | |
| 5 | 4 | |
| 6 | 12 | |
| 7 | 21 | |
| 8 | 19 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | アリルオキシプロパノールアミン類から合成されたグアニジン化合物と置換尿素化合物 β‐しゃ断作用に関する研究 | 5 |
| 12 | [The placebo (author's transl)]. | 0 |
| 13 | [Comparison of the effects of bepridil, dipyridamole, and propranolol on the cardiac activity and the coronary venous debt in anesthetized dogs]. | 14 |
| 14 | Different membrane mechanisms of action for tiemonium; a comparison with atropine and papaverine. | 1 |
| 15 | General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). I. Action on respiratory function and acute toxicity. | 5 |
| 16 | De quelques propriétés pharmacodynamiques de la niaprazine, nouvel antihistaminique. | 3 |
| 17 | [Some pharmacodynamical properties of niaprazine, a new antihistaminic agent]. | 4 |
| 18 | Faut-il conserver les notions classiques des centres d'automatisme cardiaque? | 1 |
| 19 | [Elimination of radioactive tiemonium iodide and research on its metabolites in rats and mice]. | 1 |
| 20 | [DIFFERENCE IN TOXICITY OF STRYCHNINE ACCORDING TO SEX IN MICE. PHARMACODYNAMIC APPLICATION]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.